Drugs / AZD5438
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00088790 | Jul 2004 → Dec 2005 | neoplasm | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD5438 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00088790 ↗ |
| Modality | Small molecule | — CHEMBL488436 ↗ |
| Route | Oral | “AZD5438 given orally” NCT00088790 ↗ |